# A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)

> **NCT00461110** · PHASE1 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 35 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** BMS-663513

## Key facts

- **NCT ID:** NCT00461110
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2009-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461110, "A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00461110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*